Advanced Cell Technology to Host Conference Call and Webcast to Discuss Recent Developments and Planned Acquisition of Mytogen.Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , William M. Caldwell, IV and Chief Development Officer, Dr. Pedro Huertas, to Discuss Planned Transition to Clinical Development Company and Other Topics, on Thursday, June 7, at 1:00PM ET ALAMEDA, Calif -- Advanced Cell Technology, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ACTC ACTC Apple Certified Technical Coordinator ACTC Almaden Cycle Touring Club ACTC Associated Colleges of the Twin Cities ACTC All Ceylon Tamil Congress (Sri Lanka) ACTC Association Canadienne de Télévision par Câble ) will host a conference call, which will be simultaneously webcast, on Thursday, June 7th, at 1:00PM ET. The purpose of the call is to discuss recent company developments. Among the topics to be discussed is the Company's entry into a Letter of Intent to purchase Mytogen, Inc. and its Myoblast myoblast /myo·blast/ (mi´o-blast) an embryonic cell which becomes a muscle cell or fiber.myoblas´tic my·o·blast n. A primitive muscle cell having the potential to develop into a muscle fiber. Program for the treatment of heart failure, and its plans to commence Phase II human clinical trials to treat heart failure using Mytogen's Autologous autologous /au·tol·o·gous/ (aw-tol´ah-gus) related to self; belonging to the same organism. au·tol·o·gous adj. 1. Myoblast Stem Cell Therapy stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs . The call will be hosted by William M. Caldwell, IV, Chairman and Chief Executive Officer, and Pedro Huertas, M.D., Ph.D., Chief Development Officer. William M. Caldwell, IV commented, "This planned acquisition, if completed, will hasten Advanced Cell's transformation from a preclinical development company to a clinical therapeutic company. Our Chief Development Officer, Dr. Pedro Huertas, and I are excited to have the opportunity to discuss this and other company developments with our investors and other interested parties, on Thursday's call." Details of the call are below. Participants should dial in at least ten minutes prior to the call. Thursday, June 7, 1:00PM ET --------------------------- Live participant dial-in: Toll-free: 866-585-6398 International: 416-849-9626 Replay: Toll-free: 866-245-6755 International: 416-849-2696 Passcode (for replay only): 517429 Teleconference Replay Available Until: 6/14/07, 11:59 PM A webcast of the call will be available through Advanced Cell's website, at www.advancedcell.com. The webcast will be available for replay through July 7, 2007. About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc. is a biotechnology company applying stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. technology in the emerging field of regenerative re·gen·er·a·tive adj. 1. Of, relating to, or marked by regeneration. 2. Tending to regenerate. re·gen medicine. The company operates facilities in Alameda, California Alameda is a city in Alameda County, California, United States. It is located on a small island of the same name next to Oakland, California in the San Francisco Bay. An additional part of the city is Bay Farm Island, which is adjacent to the Oakland International Airport. and Worcester, Massachusetts. For more information about the company visit www.advancedcell.com Forward-Looking Statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended March 31, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion